Article

PDF
Access to the PDF text
Service d'aide à la décision clinique
Advertising



Journal Français d'Ophtalmologie
Volume 37, n° 10
pages 763-772 (décembre 2014)
Doi : 10.1016/j.jfo.2014.06.004
Received : 31 Mars 2014 ;  accepted : 5 June 2014
Evaluation of an eyelid warming device (Blephasteam®) for the management of ocular surface diseases in France: The ESPOIR study
Évaluation de Blephasteam®, lunettes chauffantes à chaleur humide, dans la prise en charge des pathologies de la surface oculaire en France
 

Figure 1




Figure 1 : 

The Blephasteam® eyelid warming device. The device comprises a pair of goggles, a control box and power supply. Moisture is provided by wetted disposable pads.


Figure 2




Figure 2 : 

Symptomatology score. The symptomatology score was recorded by the investigator on a 0–100 visual analogue score at Day 0 and Day 21 (primary efficacy variable). Patients were asked “Please mark a vertical line on the horizontal line, indicating your level of ocular discomfort”. The scale ranged from 0mm=No discomfort to 100 mm=Maximal discomfort. Columns show mean values of 102 and 96 patients respectively, error bars show 95% CI.


Figure 3




Figure 3 : 

Ocular symptoms. Patients were queried by the investigator regarding ocular symptoms (burning and stinging sensation, sensitivity to light, watering, visual fatigue, grittiness, and erythematous/inflamed eyelids) experienced during the previous 48hours on days 0 and 21.


Figure 4




Figure 4 : 

Conjunctival hyperaemia. Conjunctival hyperaemia assessed using the ordinal McMonnies photographic scale by at slit lamp examination. Symptoms were scored from 0 (normal) to 5 (severe) on Days 0 and 21.


Figure 5




Figure 5 : 

Meibum quality. The quality of meibum was assessed at ophthalmological examination on Days 0 and 21. Data presented are from the worse eye.


Figure 6




Figure 6 : 

Lid margin examination. Individual symptoms (lid scales or crusts, lid redness, lid swelling and Meibomian gland plugging) were assessed as “None”, “Mild”, “Moderate”, “Severe” or “Very severe”at ophthalmological examination on Day 0 and Day 21. Data presented are those from the worse eye.


Figure 7




Figure 7 : 

Global efficacy. Patients responded to the question “On the whole, were you satisfied with the comfort provided by the eyelid warming device goggles during/after your sessions?” and “On the whole, were you satisfied with this treatment?” using a 0–4 ordinal scale: 0=Very satisfied; 1=Satisfied; 2=No opinion; 3=Rather dissatisfied; 4=Very dissatisfied.

EM-CONSULTE.COM is registrered at the CNIL, déclaration n° 1286925.
As per the Law relating to information storage and personal integrity, you have the right to oppose (art 26 of that law), access (art 34 of that law) and rectify (art 36 of that law) your personal data. You may thus request that your data, should it be inaccurate, incomplete, unclear, outdated, not be used or stored, be corrected, clarified, updated or deleted.
Personal information regarding our website's visitors, including their identity, is confidential.
The owners of this website hereby guarantee to respect the legal confidentiality conditions, applicable in France, and not to disclose this data to third parties.
Close
Article Outline